Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Tools
Overview
News
Currencies
International
Treasuries

Cytokinetics (NQ: CYTK )

19.67 USD +0.01 (+0.05%)
Streaming Delayed Price Updated: 9:37 AM EST, Mar 2, 2021 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Stories about Cytokinetics

< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Cytokinetics Inc (CYTK) Q4 2020 Earnings Call Transcript
CYTK earnings call for the period ending December 31, 2020. 
Tags Market News CYTK
From Motley Fool
The Daily Biotech Pulse: Merck Goes Shopping, Decision Day For Sarepta, Pfizer, Moderna Unveil Vaccine Strategies For Coronavirus Variants
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags CLBS AFIB NVCR
From Benzinga
The Week Ahead In Biotech: J&J Vaccine Adcom Meeting, Sarepta FDA Decision And Plenty Of Earnings
Biotech stocks pulled back along with the broader market in the holiday-shortened week ended Feb 19. Earnings news flow was light before ... 
Tags MDT ALIM HZNP
From Benzinga
CYTK Makes Notable Cross Below Critical Moving Average
In trading on Monday, shares of Cytokinetics Inc (CYTK) crossed below their 200 day moving average of $19.73, changing hands as low as $19.40 per share. Cytokinetics Inc shares are currently trading... 
Tags Stocks
From Market News Video
71 Biggest Movers From Yesterday
Gainers Greenwich Lifesciences Inc (NASDAQ: GLSI) shares jumped 998.1% to close at $57.10 on Wednesday after the company reported ... 
Tags Trading Ideas CLPS LITB
From Benzinga
Wall Street Analysts Say These 5 Stocks Are A Buy As The World Prepares For The Post-COVID-19 Era
From escalating tensions between the U.S. and China, the highly infectious coronavirus pandemic outbreak, and the 2020 presidential ... 
Tags Analyst Ratings Long Ideas e/commerce
From Benzinga
The Daily Biotech Pulse: Urovant In M&A Deal, Sanofi's Binary Event, Conference Presentations
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags TCRR FDA INSP
From Benzinga
The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions
Biotech stocks turned around with the broader market in the week ended Nov. 6, as investors warmed to the idea of a split Congress and a ... 
Tags PRAX Small Cap Penny Stocks
From Benzinga
Cytokinetics Hits 80-Plus Relative Strength Rating Benchmark
Cytokinetics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating from 73 to 81. 
From Investor's Business Daily
Stocks With Rising Relative Strength: Cytokinetics
Cytokinetics shows rising price performance, earning an upgrade to its IBD Relative Strength Rating 
From Investor's Business Daily
The Daily Biotech Pulse: Alzheimer's Conference Underway, Biogen's Aducanumab Briefing Doc, Supernus Earnings
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting ... 
Tags ESPR HAPP MNKD
From Benzinga
12 Healthcare Stocks Moving In Wednesday's Pre-Market Session
Gainers Digirad (NASDAQ:DRAD) stock moved upwards by 23.13% to $3.14 during Wednesday's pre-market session. The ... 
Tags Market News IGMS CYTK
From Benzinga
The Week Ahead In Biotech (Nov. 1-7): Adcom Test For Biogen's Aducanumab, Alzheimer's Conference, SMID-cap Earnings
Biotech stocks continued to sway to the tunes of the broader market in the week ended Oct. 30, which succumbed to geopolitical and ... 
Tags ATRC XNCR GH
From Benzinga
Investors Pick Up CYTK 31.5% Lower Than Its Secondary Stock Offering
Looking back to 95 days ago, Cytokinetics Inc (CYTK) priced a 7,291,667 share secondary stock offering at $24.00 per share. Buyers in that offering made a considerable investment into the company,... 
Tags Stocks
From Market News Video
35 Stocks Moving in Wednesday's Pre-Market Session
Gainers Medalist Diversified REIT, Inc. (NASDAQ: MDRR) rose 138.3% to $2.74 in pre-market trading. Medalist Diversified REIT ... 
Tags NXTD THTX Markets
From Benzinga
64 Biggest Movers From Yesterday
Gainers AgeX Therapeutics, Inc. (NYSE: AGE) shares climbed 193.8% to close at $2.48 on Thursday following an amended 13D filing ... 
Tags SOL SKYS MMYT
From Benzinga
Mid-Afternoon Market Update: Crude Oil Rises Over 3%; Consumer Portfolio Services Shares Spike Higher
Toward the end of trading Thursday, the Dow traded up 0.38% to 28411.68 while the NASDAQ rose 0.35% to 11404.34. The S&P also rose, ... 
Tags Intraday Update NOG CYTK
From Benzinga
Amgen, Cytokinetics Partnership Disappoints With Data On Heart Treatment
Amgen and Cytokinetics disappointed with key Phase 3, final-stage trial results for a heart treatment that aims to reduce cardiovascular death; sending CYTK crashing and AMGN down hard. 
From Investor's Business Daily
12 Healthcare Stocks Moving In Thursday's Intraday Session
Gainers Alphatec Holdings (NASDAQ:ATEC) stock moved upwards by 26.9% to $8.73 during Thursday's regular session. Trading ... 
Tags Healthcare Stocks intraday movers XCUR Movers
From Benzinga
Mid-Day Market Update: Eaton Vance Jumps Following Acquisition News; Cytokinetics Shares Plunge
Midway through trading Thursday, the Dow traded up 0.50% to 28446.36 while the NASDAQ rose 0.41% to 11,411.66. The S&P also rose, ... 
Tags Intraday Update NOG CYTK
From Benzinga
48 Stocks Moving In Thursday's Mid-Day Session
Gainers AgeX Therapeutics, Inc. (NYSE: AGE) jumped 305.1% to $3.42 following an amended 13D filing showing Juvenescence Limited ... 
Tags RUN BYFC AREC
From Benzinga
Why Cytokinetics Is Trading Lower Today
Cytokinetics (NASDAQ: CYTK) shares are trading lower on Thursday after the company, Amgen and Servier announced topline results from ... 
Tags why it's moving Benzinga General
From Benzinga
Return On Capital Employed Overview: Cytokinetics
During Q2, Cytokinetics's (NASDAQ: CYTK) reported sales totaled $3.59 million. Despite a 6.57% in earnings, the company posted a ... 
Tags News Market News Benzinga
From Benzinga
Mid-Morning Market Update: Markets Open Higher; Domino's Pizza Earnings Miss Estimates
Following the market opening Thursday, the Dow traded up 0.29% to 28384.27 while the NASDAQ rose 0.39% to 11408.88. The S&P also ... 
Tags ATEC Markets MS
From Benzinga
Here's Why Bristol Myers Offered MyoKardia $13.1 Billion
Cardiovascular drugs have been unsuccessful investments in recent years, but this one makes sense. 
Tags Market News CYTK MYOK
From Motley Fool
The Daily Biotech Pulse: Pfizer, BioNTech Begin European Filing For Coronavirus Vaccine, Y-mAbs BLA Rejected, GlycoMimetics Granted Rare Pediatric Disease Designation
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting ... 
Tags SGEN BNTX BBIO
From Benzinga
62 Biggest Movers From Yesterday
Gainers Westwater Resources, Inc. (NASDAQ: WWR) shares surged 87.3% to close at $8.28 on Monday after surging 49% on Friday. The ... 
Tags Top Gainers CNK Consumer Discretionary
From Benzinga
Bristol Myers Squibb To Add To Heart Treatment Portfolio With $13.1 Billion Acquisition
Bristol Myers Squibb said it reached an agreement to acquire MyoKardia for $13.1 billion, adding to its portfolio of treatments for cardiovascular diseases but sending BMY stock down early. 
From Investor's Business Daily
50 Stocks Moving In Monday's Mid-Day Session
Gainers MyoKardia, Inc. (NASDAQ: MYOK) shares climbed 58.2% to $220.80 after Bristol-Myers Squibb announced a multi-billion ... 
Tags AMC PACB AMRH
From Benzinga
We Did The Math SLYG Can Go To $69
Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and... 
Tags ETFs
From ETF Channel
< Previous 1 2 3 4 5 6 7 8 9
...
17 18 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.